| Cat. No. |
Product Name / Activity |
| 6764 |
B 973B |
| Positive allosteric modulator of α7 nAChRs; analgesic |
| 6009 |
B I09 |
| IRE1 endonuclease inhibitor; cell permeable |
| 1802 |
2B-(SP) |
| Selective GSK-3 phosphopeptide substrate |
| 2759 |
B-HT 920 |
| D2 agonist; also α2-adrenoceptor agonist and 5-HT3 antagonist |
| 2758 |
B-HT 933 dihydrochloride |
| Selective α2 agonist |
| 6392 |
B02 |
| RAD51 recombinase inhibitor |
| 2855 |
B2 |
| Promotes inclusion formation in Huntington's and Parkinson's diseases |
| 5600 |
BA 1 |
| Potent bombesin agonist |
| 1326 |
BADGE |
| PPARγ antagonist |
| 3606 |
BAG 956 |
| Dual PI 3-kinase and PDPK1 (PDK1) inhibitor |
| 1763 |
BAM (8-22) |
| Potent MRGPRX1 agonist |
| 5737 |
BAM 15 |
| Mitochondrial protonophore uncoupler |
| 1650 |
BAM 22P |
| MRGPRX1 agonist; also opioid receptor agonist |
| 4810 |
BAM 7 |
| Selective Bax activator; induces Bax-mediated apoptosis |
| 2786 |
BAPTA |
| Selective calcium chelator |
| 2787 |
BAPTA AM |
| Cell-permeable Ca2+ chelator |
| 6857 |
BAY 293 |
| Potent KRas/SOS1 interaction inhibitor |
| 6906 |
BAY 293 Negative Control |
| Negative control for BAY 293 (Cat. No. 6857) |
| 5970 |
BAY 299 |
| Potent and selective BRD1 and TAF1 inhibitor |
| 4430 |
BAY 41-2272 |
| Soluble guanylyl cyclase (sGC) activator |
| 5708 |
BAY 41-8543 |
| Guanylyl cyclase (sGC) stimulator |
| 6052 |
BAY 58-2667 hydrochloride |
| Potent soluble guanylyl cyclase (sGC) activator |
| 5991 |
BAY 598 |
| Potent and selective SMYD2 inhibitor |
| 4472 |
BAY 60-6583 |
| Potent A2B agonist; cardioprotective |
| 6561 |
BAY 6035 |
| Potent and selective SMYD3 inhibitor |
| 6389 |
BAY 677 |
| Inactive control for BAY 678 (Cat.No.5706) |
| 5706 |
BAY 678 |
| Potent and selective cell-permeable human neutrophil elastase (HNE) inhibitor |
| 6817 |
BAY 8002 |
| Potent dual MCT1/2 inhibitor; orally bioavailable |
| 6579 |
BAY 826 |
| Potent Tie2 inhibitor |
| 6980 |
BAY 87-2243 |
| Mitochondrial complex I inhibitor |
| 6199 |
BAY 876 |
| Potent and selective GLUT1 inhibitor |
| 3541 |
BAY-X 1005 |
| Orally active 5-lipoxygenase activating protein (FLAP) inhibitor |
| 2732 |
BAY-u 3405 |
| Dual TP/DP2 (CRTH2) receptor antagonist |
| 5266 |
BAZ2-ICR |
| Selective BAZ2 inhibitor |
| 4372 |
BC 11 hydrobromide |
| Selective urokinase (uPA) inhibitor |
| 4496 |
BC 11-38 |
| Selective PDE11 inhibitor |
| 6791 |
BC-LI-0186 New |
| Leucyl-tRNA synthase (TRS)/Ras-related GTP-binding protein D (RagD) interaction inhibitor |
| 5027 |
BCH |
| LAT1 inhibitor |
| 1048 |
1-BCP |
| Modulates AMPA-mediated responses |
| 3875 |
BCTC |
| TRPV1 antagonist |
| 0511 |
BD 1008 dihydrobromide |
| Potent, selective σ ligand |
| 0956 |
BD 1047 dihydrobromide |
| σ1 selective antagonist |
| 0883 |
BD 1063 dihydrochloride |
| Selective σ1 ligand, putative antagonist |
| 3579 |
5-BDBD |
| Potent and selective P2X4 antagonist |
| 2837 |
BDNF (human) |
| Activates TrkB and p75 receptors |
| 5184 |
BDS I |
| Potent and reversible Kv3.4 potassium channel blocker; neuroprotective |
| 5468 |
BDY 630-X, SE |
| Red BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester |
| 5469 |
BDY 650-X, SE |
| Far-red BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester |
| 5465 |
BDY FL, SE |
| Green BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester |
| 5620 |
BDY FL-X, SE |
| Green BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester |
| 5466 |
BDY TMR-X, SE |
| Yellow BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester |
| 5467 |
BDY TR-X, SE |
| Orange/red BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester |
| 4778 |
BETP |
| Positive allosteric modulator of GLP-1 receptors |
| 3743 |
BF 2649 hydrochloride |
| Potent and selective H3 inverse agonist |
| 6246 |
BF 738735 |
| Potent and selective PI 4-kinase IIIβ inhibitor; broad spectrum enterovirus replication inhibitor |
| 0348 |
2-BFI hydrochloride |
| Potent, selective I2 ligand. Putative agonist |
| 5327 |
BGC 20-1531 hydrochloride |
| High affinity and selective EP4 antagonist |
| 3326 |
BGC 20-761 |
| High affinity 5-HT6 antagonist |
| 6703 |
BGP 15 |
| PARP inhibitor; cytoprotectant |
| 3313 |
rac BHFF |
| Potent and selective postitive allosteric modulator of GABAB receptors |
| 6116 |
BHPI |
| ERα antagonist; also activates unfolded protein response; active in vivo |
| 1236 |
BHQ |
| Inhibitor of SERCA ATPase |
| 6518 |
BI 01383298 |
| Potent and selective SLC13A5 (Na+/citrate cotransporter) inhibitor |
| 4641 |
BI 6015 |
| Hepatocyte nuclear factor 4α (HNF4α) antagonist |
| 5300 |
BI 605906 |
| Selective IKKβ inhibitor |
| 3314 |
BI 78D3 |
| Selective, competitive JNK inhibitor |
| 6665 |
BI 9321 |
| Nuclear receptor-binding SET domain (NSD) 3 antagonist; selectively binds PWWP1 domain |
| 5590 |
BI 9564 |
| Potent and selective BRD9 and BRD7 inhibitor; orally active |
| 4561 |
BIBN 4096 |
| Potent and selective CGRP antagonist |
| 2412 |
BIBO 3304 trifluoroacetate |
| Highly selective NPY Y1 receptor antagonist |
| 2707 |
BIBP 3226 trifluoroacetate |
| Mixed NPY Y1 and NPFF receptor antagonist |
| 2981 |
BIBR 1532 |
| Selective telomerase inhibitor |
| 2417 |
BIBU 1361 dihydrochloride |
| Selective inhibitor of EGFR-kinase |
| 2416 |
BIBX 1382 dihydrochloride |
| Highly selective EGFR-kinase inhibitor |
| 4608 |
BIIB 021 |
| Selective Hsp90 inhibitor |
| 1700 |
BIIE 0246 |
| Potent, selective non-peptide NPY Y2 receptor antagonist |
| 2716 |
BIM 187 |
| Bombesin/GRP receptor agonist |
| 2717 |
BIM 189 |
| Bombesin antagonist |
| 3237 |
BIM 23042 |
| Selective neuromedin B receptor antagonist (NMB-R, BB1) |
| 1844 |
BIM 23056 |
| sst ligand |
| 4374 |
BIMU 8 |
| Potent 5-HT4 agonist |
| 4048 |
BINA |
| Selective positive allosteric modulator of mGlu2 receptors |
| 3194 |
BIO |
| Potent GSK-3 inhibitor; also inhibits cdks |
| 3910 |
BIO 1211 |
| Selective α4β1 (VLA-4) inhibitor |
| 5051 |
BIO 5192 |
| Highly potent and selective inhibitor of integrin α4β1 (VLA-4) |
| 3874 |
BIO-acetoxime |
| Selective GSK-3α/β inhibitor |
| 5989 |
BIRB 796 |
| High affinity and selective p38 kinase inhibitor |
| 4776 |
BIRT 377 |
| Potent negative allosteric modulator of LFA-1 |
| 5216 |
BIS-TRIS |
| Commonly used buffering agent |
| 5375 |
BIX |
| BiP (Hsp70-5) ER chaperone inducer |
| 3364 |
BIX 01294 |
| GLP and G9a inhibitor |
| 4842 |
BIX 02189 |
| Selective MEK5 and ERK5 inhibitor |
| 5512 |
BIX NHE1 inhibitor |
| Potent and selective NHE1 inhibitor |
| 3797 |
BL 1249 |
| K2P2.1 (TREK-1) and K2P10.1 (TREK-2) activator |
| 2538 |
L-BMAA hydrochloride |
| Neurotoxic amino acid |
| 5417 |
BMH 21 |
| RNA polymerase 1 inhibitor; also p53 pathway activator |
| 5488 |
BML 111 |
| FPR2 (lipoxin A4 receptor) agonist |
| 1441 |
BMS 182874 hydrochloride |
| Highly selective, orally active non-peptide ETA antagonist |
| 2665 |
BMS 191011 |
| Potent BKCa (KCa1.1) channel opener |
| 3242 |
BMS 193885 |
| Potent, competitive NPY Y1 receptor antagonist |
| 3660 |
BMS 195614 |
| Selective RARα antagonist |
| 5654 |
BMS 265246 |
| Cdk inhibitor; potently inhibits cdk1 and cdk2 |
| 2870 |
BMS 299897 |
| Potent γ-secretase inhibitor |
| 4609 |
BMS 303141 |
| ATP citrate lyase inhibitor; orally bioavailable |
| 5258 |
BMS 309403 |
| Potent and selective FABP4 inhibitor |
| 4806 |
BMS 345541 |
| Selective allosteric inhibitor of IKK; anti-inflammatory |
| 3409 |
BMS 453 |
| Synthetic retinoid and RARβ agonist; also RARα and RARγ antagonist |
| 4053 |
BMS 470539 dihydrochloride |
| Potent, selective MC1 receptor agonist |
| 3509 |
BMS 493 |
| Pan-RAR inverse agonist |
| 5009 |
BMS 509744 |
| Potent and selective ITK inhibitor |
| 4774 |
BMS 536924 |
| Dual IR/IGF1R inhibitor |
| 5274 |
BMS 564929 |
| Highly potent and muscle-selective androgen receptor (AR) agonist |
| 5492 |
BMS 566419 |
| Inosine monophosphatase dehydrogenase (IMPDH) inhibitor |
| 5022 |
BMS 599626 dihydrochloride |
| Potent, selective EGFR and ErbB2 inhibitor |
| 6069 |
BMS 605541 |
| Potent VEGFR-2 inhibitor |
| 4970 |
BMS 688521 |
| Potent inhibitor of the LFA-1/ICAM interaction |
| 3505 |
BMS 753 |
| RARα-selective agonist |
| 5762 |
BMS 795311 |
| Potent cholesteryl ester transfer protein (CETP) inhibitor |
| 3410 |
BMS 961 |
| Selective RARγ agonist |
| 6974 |
BMS 986094 |
| Inhibitor of HCV RNA-dependent RNA polymerase NS5b; potent hepatitis C virus (HCV) replication inhibitor |
| 5983 |
BMS 986187 |
| Potent positive allosteric modulator of δ receptors |
| 3129 |
BMS CCR2 22 |
| High affinity, potent CCR2 antagonist |
| 5123 |
BMX-IN-1 |
| Potent and irreversible BMX inhibitor |
| 1440 |
BMY 14802 hydrochloride |
| Sigma antagonist. Antipsychotic agent |
| 1442 |
BMY 45778 |
| Non-prostanoid prostacyclin IP receptor partial agonist |
| 1006 |
BMY 7378 dihydrochloride |
| Selective α1D antagonist |
| 0899 |
BNTX maleate |
| Standard δ1 selective antagonist |
| 6047 |
BOP |
| Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs |
| 0556 |
BP 554 maleate |
| Selective 5-HT1A agonist |
| 5301 |
BPTES |
| Selective allosteric glutaminase (GLS1) inhibitor |
| 6078 |
BPTU |
| P2Y1 allosteric antagonist |
| 1500 |
BQ 788 sodium salt |
| Selective ETB antagonist |
| 1188 |
BQ-123 |
| Selective ETA antagonist |
| 1189 |
BQ-3020 |
| Selective ETB agonist |
| 6872 |
BQCA |
| Positive allosteric modulator of M1 receptors |
| 5312 |
BRACO 19 trihydrochloride |
| Telomerase inhibitor |
| 6010 |
BRD 4354 |
| HDAC5 and HDAC9 inhibitor |
| 6282 |
BRD 4770 |
| G9a inhibitor and S-adenosyl methionine mimetic; cell permeable |
| 6438 |
BRD 6989 |
| Cdk8 inhibitor; enhances IL-10 production |
| 4037 |
BRD 7389 |
| Ribosomal S6 kinase inhibitor |
| 6284 |
BRD 73954 |
| Dual histone deacetylase (HDAC) 6/8 inhibitor |
| 5230 |
BRD 7552 |
| PDX1 transcription factor inducer; increases insulin expression |
| 6040 |
BRD 9757 |
| Potent and selective HDAC6 inhibitor |
| 1207 |
BRL 15572 hydrochloride |
| Selective h5-HT1D antagonist |
| 0948 |
BRL 37344, sodium salt |
| β3 agonist |
| 1133 |
BRL 44408 maleate |
| Selective α2A antagonist |
| 2237 |
BRL 50481 |
| Selective PDE7 inhibitor |
| 0699 |
BRL 52537 hydrochloride |
| Potent and selective κ agonist |
| 1129 |
BRL 54443 |
| Potent 5-ht1E and 5-HT1F agonist |
| 5608 |
BS 181 dihydrochloride |
| Selective cdk7 inhibitor |
| 5817 |
BSI 201 |
| PARP-1 inhibitor |
| 6921 |
BSJ-03-123 |
| Selective Cdk6 degrader |
| 6938 |
BSJ-03-204 |
| Selective Cdk4/6 degrader |
| 6937 |
BSJ-04-132 |
| Selective Cdk4 degrader |
| 6922 |
BSJ-Bump |
| Negative control for BSJ-03-123 (Cat. No. 6921) |
| 5399 |
BTB1 |
| Selective and ATP-competitive Kif18A inhibitor |
| 6940 |
BTD |
| Selective TRPC5 activator |
| 1870 |
BTS |
| Selective inhibitor of skeletal muscle myosin II ATPase activity |
| 2322 |
BTS 54-505 hydrochloride |
| Potent 5-HT and NA reuptake inhibitor (SNRI); active metabolite of sibutramine (Cat. No. 2290) |
| 4724 |
BTT 3033 |
| Selective inhibitor of integrin α2β1 |
| 4204 |
BTZO 1 |
| MIF binder |
| 0725 |
BU 224 hydrochloride |
| Potent, selective I2 ligand. Putative antagonist |
| 1091 |
BU 226 hydrochloride |
| Potent, highly selective I2 ligand |
| 0726 |
BU 239 hydrochloride |
| Potent, highly selective I2 ligand |
| 2176 |
BVT 948 |
| Non-competitive protein tyrosine phosphatase inhibitor |
| 1663 |
BW 373U86 |
| Potent, selective non-peptide δ agonist |
| 1059 |
BW 723C86 hydrochloride |
| 5-HT2B agonist |
| 1304 |
BW-B 70C |
| 5-Lipoxygenase inhibitor |
| 5545 |
BX 430 |
| Selective P2X4 allosteric antagonist |
| 3496 |
BX 471 |
| Potent, selective CCR1 antagonist |
| 2769 |
BX 513 hydrochloride |
| Selective CCR1 antagonist |
| 4318 |
BX 795 |
| PDPK1 (PDK1) inhibitor |
| 2866 |
BYK 191023 dihydrochloride |
| Potent and selective inhibitor of iNOS |
| 3734 |
BYK 204165 |
| Selective PARP-1 inhibitor |
| 3735 |
BYK 49187 |
| PARP-1 and PARP-2 inhibitor |
| 0796 |
(R)-Baclofen |
| Selective GABAB agonist; active enantiomer of (RS)-Baclofen (Cat. No. 0417) |
| 0417 |
(RS)-Baclofen |
| Selective GABAB agonist |
| 1334 |
Bafilomycin A1 |
| H+-ATPase (vacuolar) inhibitor |
| 1761 |
Baicalein |
| 5- and 12-Lipoxygenase inhibitor |
| 5585 |
Balicatib |
| Potent and selective cathepsin K inhibitor |
| 4219 |
Banoxantrone dihydrochloride |
| Prodrug topoisomerase II inhibitor |
| 7222 |
Baricitinib New |
| Highly potent JAK1 and JAK2 inhibitor; also inhibits JAK3 and Tyk2 |
| 2961 |
Batimastat |
| Potent, broad spectrum MMP inhibitor |
| 2160 |
Bax channel blocker |
| Allosteric inhibitor of Bax channel activation |
| 1785 |
Bax inhibitor peptide V5 |
| Inhibitor of Bax-mediated apoptosis |
| 1743 |
Bay 11-7085 |
| Irreversible inhibitor of TNF-α-induced IκBα phosphorylation |
| 1744 |
Bay 11-7821 |
| E2 ubiquitin (Ub) conjugating enzymes inhibitor |
| 2501 |
Bay 36-7620 |
| mGlu1 inverse agonist |
| 2711 |
Bay 55-9837 |
| Potent and selective VPAC2 agonist |
| 2500 |
Bay 59-3074 |
| CB1/CB2 receptor partial agonist |
| 1544 |
(±)-Bay K 8644 |
| CaV1.x activator |
| 1545 |
(R)-(+)-Bay K 8644 |
| CaV1.x blocker; (R)-(+)-enantiomer of (±)-Bay K 8644; also TMEM176B inhibitor |
| 1546 |
(S)-(-)-Bay K 8644 |
| CaV1.x activator; (S)-(-)-enantiomer of (±)-Bay K 8644 |
| 5263 |
Bazedoxifene acetate |
| Potent and selective estrogen receptor modulator (SERM) |
| 5929 |
BeKm 1 |
| Potent and selective KV11.1 (hERG) channel blocker |
| 4283 |
Begacestat |
| γ-secretase inhibitor; lowers Aβ40 and Aβ42 levels |
| 2578 |
Benazepril hydrochloride |
| Angiotensin-converting enzyme (ACE) inhibitor |
| 3681 |
Bendamustine hydrochloride |
| Cytostatic agent; exhibits DNA alkylating and purine analog properties |
| 5273 |
Bengamide B |
| Potent inhibitor of NF-κB activation |
| 3934 |
Benidipine hydrochloride |
| Non-selective Cav blocker; also mineralocorticoid receptor antagonist |
| 3380 |
Benzamil |
| NCX inhibitor, Deg/ENaC channel blocker; amiloride (Cat. No. 0890) derivative |
| 5420 |
Benzbromarone |
| TMEM16A/B calcium-activated chloride channel (CaCC) blocker |
| 0424 |
Benzoquinonium dibromide |
| nAChR antagonist |
| 0754 |
N-Benzylnaltrindole hydrochloride |
| Selective non-peptide δ2 antagonist |
| 4117 |
Bepridil hydrochloride |
| Non-selective Ca2+ channel blocker; also NCX inhibitor |
| 4180 |
Beraprost sodium |
| Potent prostacyclin IP receptor agonist |
| 1956 |
Bestatin |
| Aminopeptidase inhibitor |
| 0906 |
Betaxolol hydrochloride |
| Selective β1 antagonist |
| 3906 |
Betulinic acid |
| Antitumor and anti-HIV agent; activates NF-κB. Also TGR5 agonist |
| 5819 |
Bexarotene |
| Potent and selective RXR agonist |
| 3389 |
Bicalutamide |
| Non-steroidal androgen receptor antagonist |
| 4357 |
Bicifadine hydrochloride |
| Noradrenalin, 5-HT and dopamine re-uptake inhibitor |
| 5881 |
Bicine |
| General purpose buffer |
| 2503 |
(-)-Bicuculline methiodide |
| GABAA antagonist; more water soluble version of (+)-bicuculline (Cat. No. 0130) |
| 0109 |
(-)-Bicuculline methobromide |
| GABAA antagonist; more water soluble version of (+)-bicuculline (Cat. No. 0130) |
| 0131 |
(-)-Bicuculline methochloride |
| GABAA antagonist; more water soluble version of (+)-bicuculline (Cat. No. 0130) |
| 0130 |
(+)-Bicuculline |
| Potent GABAA antagonist |
| 0767 |
Bifemelane hydrochloride |
| Non-selective MAO inhibitor |
| 6304 |
BigLEN (mouse) |
| GPR171 agonist |
| 0347 |
nor-Binaltorphimine dihydrochloride |
| Selective κ antagonist |
| 3349 |
Biocytin |
| Versatile marker for neuroanatomical investigations |
| 3526 |
BIM, Biotinylated |
| Bim peptide fragment |
| 6571 |
Biotin-11-dUTP |
| Biotin-labeled dUTP |
| 6572 |
Biotin-LC-NAD+ |
| Biotinylated analog of β-NAD+; commonly used reagent in LSD1 and PARP1 assays |
| 6573 |
Biotin-NAD+ |
| Biotinylated-NAD+; substrate for ADP-ribosylation |
| 6241 |
Biotinyl Tyramide |
| Reagent widely used for signal amplification in IHC and FISH |
| 5372 |
Bioymifi |
| DR5 (TRAIL receptor) agonist; induces apoptosis |
| 2853 |
Biperiden hydrochloride |
| Muscarinic receptor antagonist; some selectivity for M1 |
| 5348 |
6,8-Bis(benzylthio)octanoic acid |
| PDH and KGDH inhibitor |
| 0918 |
3α-Bis-(4-fluorophenyl) methoxytropane hydrochloride |
| Potent dopamine uptake inhibitor |
| 4128 |
Bisindolylmaleimide II |
| Potent PKC inhibitor; also potent nAChR antagonist |
| 0914 |
(±)-Bisoprolol hemifumarate |
| β1 antagonist |
| 5502 |
Blasticidin S HCl |
| Antibiotic; selection reagent for bis, bsr and BSD transformed cells |
| 1853 |
(R)-(+)-Blebbistatin |
| Selective inhibitor of myosin II ATPase activity. Inactive enantiomer of (±)-blebbistatin (Cat. No. 1760) |
| 1852 |
(S)-(-)-Blebbistatin |
| Selective inhibitor of myosin II ATPase activity. Active enantiomer of (±)-blebbistatin (Cat. No. 1760) |
| 1760 |
(±)-Blebbistatin |
| Selective inhibitor of myosin II ATPase activity |
| 5255 |
6-Bnz-cAMP sodium salt |
| Cell permeable cAMP analog |
| 3730 |
Boc-MLF |
| FPR1 antagonist |
| 1149 |
Bombesin |
| Involved in gastrointestinal tract function |
| 3422 |
[D-Phe12,Leu14]-Bombesin |
| Bombesin receptor antagonist |
| 2371 |
Bombinakinin M |
| Potent bradykinin agonist |
| 2370 |
Bombinakinin-GAP |
| Bioactive, bradykinin-related peptide |
| 4706 |
Borrelidin |
| Antiangiogenic; inhibits threonyl-tRNA synthetase |
| 6232 |
Bosentan |
| High affinity dual ETA and ETB receptor antagonist;orally bioavailable |
| 4361 |
Bosutinib |
| Dual Src-Abl inhibitor; antiproliferative |
| 5217 |
Bovine Serum Albumin |
| Widely used blocking agent for ELISA and blotting |
| 3004 |
Bradykinin |
| Endogenous agonist at bradykinin receptors (B2 > B1) |
| 3230 |
Sar-[D-Phe8]-des-Arg9-Bradykinin |
| Potent and selective B1 agonist |
| 3225 |
Lys-[Des-Arg9]Bradykinin |
| Selective B1 agonist |
| 3229 |
[Phe8Ψ(CH-NH)-Arg9]-Bradykinin |
| Selective B2 agonist |
| 3522 |
Brain natriuretic peptide (1-32) (human) |
| Endogenous peptide agonist at ANP receptor A (NPR1) |
| 1231 |
Brefeldin A |
| Disrupts protein translocation to Golgi |
| 6196 |
Brequinar sodium |
| Potent and selective DHODH inhibitor |
| 3568 |
Bretazenil |
| Benzodiazepine partial agonist |
| 1140 |
8-Bromo-cAMP, sodium salt |
| Cell-permeable cAMP analog |
| 1089 |
8-Bromo-cGMP, sodium salt |
| cGMP analog; activates PKG |
| 0427 |
Bromocriptine mesylate |
| D2-like agonist (D2>D3>D4) |
| 3549 |
3-Bromocytisine |
| Potent α4β4, α4β2 and α7 nAChR agonist |
| 5015 |
5-BrdU |
| Synthetic thymidine analog; used for cell proliferation assays |
| 0735 |
3-Bromo-7-nitroindazole |
| Selective nNOS inhibitor |
| 5218 |
Bromophenol Blue |
| Dye used in gel loading buffers |
| 4758 |
Bromosporine |
| Broad spectrum bromodomain inhibitor |
| 4316 |
Bropirimine |
| Immunomodulatory and antitumor compound |
| 2383 |
Bryostatin 1 |
| Protein kinase C activator |
| 5238 |
Bryostatin 3 |
| Potent protein kinase C activator |
| 2671 |
Budesonide |
| Synthetic glucocorticoid; anti-inflammatory and chemopreventive |
| 3108 |
Bumetanide |
| Na+/2Cl-/K+ (NKCC) symporter inhibitor |
| 2133 |
α-Bungarotoxin |
| Selective α7 nAChR antagonist |
| 2808 |
Buprenorphine hydrochloride |
| NOP agonist; also displays mixed action δ, κ and μ receptors |
| 2831 |
Bupropion hydrochloride |
| Non-selective inhibitor of dopamine and noradrenalin transporters |
| 0962 |
Buspirone hydrochloride |
| 5-HT1A partial agonist |
| 1323 |
Butabindide oxalate |
| High affinity CCK-inactivating serine protease inhibitor |
| 5791 |
Bz 423 |
| ATP synthase inhibitor; proapoptotic |
| 3312 |
BzATP triethylammonium salt |
| Photoaffinity label for ATPase; also P2X7 agonist and P2X1/P2Y1 partial agonist |
| 6786 |
BzF |
| Photoreactive unnatural amino acid; photo-crosslinker |